JP2013501733A5 - - Google Patents

Download PDF

Info

Publication number
JP2013501733A5
JP2013501733A5 JP2012524066A JP2012524066A JP2013501733A5 JP 2013501733 A5 JP2013501733 A5 JP 2013501733A5 JP 2012524066 A JP2012524066 A JP 2012524066A JP 2012524066 A JP2012524066 A JP 2012524066A JP 2013501733 A5 JP2013501733 A5 JP 2013501733A5
Authority
JP
Japan
Prior art keywords
alkyl
heteroaryl
compound
formula
cycloalkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
JP2012524066A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013501733A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CA2010/001229 external-priority patent/WO2011017800A1/en
Publication of JP2013501733A publication Critical patent/JP2013501733A/ja
Publication of JP2013501733A5 publication Critical patent/JP2013501733A5/ja
Ceased legal-status Critical Current

Links

JP2012524066A 2009-08-10 2010-08-06 １，３−プロパンジスルホン酸を送達するための方法、化合物、および組成物 Ceased JP2013501733A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US23259709P 2009-08-10 2009-08-10
US61/232,597 2009-08-10
PCT/CA2010/001229 WO2011017800A1 (en) 2009-08-10 2010-08-06 Methods, compounds, and compositions for delivering 1,3-propan ed isulfonic acid

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2015179480A Division JP2016034960A (ja) 2009-08-10 2015-09-11 １，３−プロパンジスルホン酸を送達するための方法、化合物、および組成物

Publications (2)

Publication Number Publication Date
JP2013501733A JP2013501733A (ja) 2013-01-17
JP2013501733A5 true JP2013501733A5 (enExample) 2013-08-29

Family

ID=43585812

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2012524066A Ceased JP2013501733A (ja) 2009-08-10 2010-08-06 １，３−プロパンジスルホン酸を送達するための方法、化合物、および組成物
JP2015179480A Pending JP2016034960A (ja) 2009-08-10 2015-09-11 １，３−プロパンジスルホン酸を送達するための方法、化合物、および組成物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2015179480A Pending JP2016034960A (ja) 2009-08-10 2015-09-11 １，３−プロパンジスルホン酸を送達するための方法、化合物、および組成物

Country Status (15)

Country Link
US (2) US9051248B2 (enExample)
EP (1) EP2464626A4 (enExample)
JP (2) JP2013501733A (enExample)
KR (1) KR20120087878A (enExample)
CN (1) CN102471248B (enExample)
AU (1) AU2010282170B2 (enExample)
BR (1) BR112012002780A2 (enExample)
CA (1) CA2768877A1 (enExample)
EA (1) EA201290007A1 (enExample)
IL (1) IL217572A (enExample)
MX (1) MX2012001671A (enExample)
NZ (1) NZ598085A (enExample)
SG (2) SG10201600910YA (enExample)
WO (1) WO2011017800A1 (enExample)
ZA (1) ZA201201352B (enExample)

Families Citing this family (61)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2013501733A (ja) * 2009-08-10 2013-01-17 ビーエイチアイ リミテッド パートナーシップ １，３−プロパンジスルホン酸を送達するための方法、化合物、および組成物
WO2011107867A2 (en) * 2010-03-05 2011-09-09 Mahesh Kandula Compound and composition and their use in the treatment of diseases related to copper retention
WO2014037832A2 (en) 2012-09-06 2014-03-13 Mahesh Kandula Compositions and methods for the treatment of epilepsy and neurological diseases
JP2015519333A (ja) 2012-05-07 2015-07-09 セリックスビオ プライヴェート リミテッド 神経疾患の治療のための組成物および方法
CA2873093A1 (en) 2012-05-07 2013-11-14 Cellixbio Private Limited Compositions and methods for treatment of neuromuscular disorders and neurodegenerative disorders
WO2013167990A1 (en) 2012-05-07 2013-11-14 Mahesh Kandula Compositions and methods for the treatment of depression
WO2013168025A1 (en) 2012-05-08 2013-11-14 Mahesh Kandula Compositions and methods for treatment of blood clotting disorders
US9434704B2 (en) 2012-05-08 2016-09-06 Cellix Bio Private Limited Compositions and methods for the treatment of neurological degenerative disorders
WO2013168023A1 (en) 2012-05-08 2013-11-14 Mahesh Kandula Compositions and methods for treatment of parkinson's disease
WO2013167992A1 (en) 2012-05-08 2013-11-14 Mahesh Kandula Compositions and methods for the treatment of inflammatory disorders
US9522884B2 (en) 2012-05-08 2016-12-20 Cellix Bio Private Limited Compositions and methods for the treatment of metabolic disorders
US9339484B2 (en) 2012-05-10 2016-05-17 Cellix Bio Private Limited Compositions and methods for the treatment of restless leg syndrome and fibromyalgia
WO2013167999A2 (en) 2012-05-10 2013-11-14 Mahesh Kandula Compositions and methods for the treatment of neurologic diseases
WO2013168004A2 (en) 2012-05-10 2013-11-14 Mahesh Kandula Compositions and methods for the treatment of fibromyalgia pain
WO2013168012A1 (en) 2012-05-10 2013-11-14 Mahesh Kandula Compositions and methods for the treatment of respiratory disorders
US9273061B2 (en) 2012-05-10 2016-03-01 Cellix Bio Private Limited Compositions and methods for the treatment of chronic pain
WO2013168015A1 (en) 2012-05-10 2013-11-14 Mahesh Kandula Compositions and methods for the treatment of asthma and allergy
WO2013168033A1 (en) 2012-05-10 2013-11-14 Mahesh Kandula Compositions and methods for treatment of neurologic diseases
US9499527B2 (en) 2012-05-10 2016-11-22 Cellix Bio Private Limited Compositions and methods for the treatment of familial amyloid polyneuropathy
WO2013168002A1 (en) 2012-05-10 2013-11-14 Mahesh Kandula Compositions and methods for the treatment of neurological conditions
WO2013168016A1 (en) * 2012-05-10 2013-11-14 Mahesh Kandula Compositions and methods for the treatment of metabolic syndrome
US9573927B2 (en) 2012-05-10 2017-02-21 Cellix Bio Private Limited Compositions and methods for the treatment of severe pain
WO2013167997A2 (en) 2012-05-10 2013-11-14 Mahesh Kandula Compositions and methods for the treatment of metabolic syndrome
US9321775B2 (en) 2012-05-10 2016-04-26 Cellix Bio Private Limited Compositions and methods for the treatment of moderate to severe pain
US9434729B2 (en) 2012-05-23 2016-09-06 Cellix Bio Private Limited Compositions and methods for the treatment of periodontitis and rheumatoid arthritis
US9765020B2 (en) 2012-05-23 2017-09-19 Cellix Bio Private Limited Dichlorophenyl-imino compounds and compositions, and methods for the treatment of mucositis
WO2013175376A2 (en) 2012-05-23 2013-11-28 Mahesh Kandula Compositions and methods for the treatment of local pain
US9227974B2 (en) 2012-05-23 2016-01-05 Cellex Bio Private Limited Compositions and methods for the treatment of respiratory disorders
CA2873098A1 (en) 2012-05-23 2013-11-28 Cellixbio Private Limited Compositions and methods for the treatment of multiple sclerosis
WO2013175357A2 (en) 2012-05-23 2013-11-28 Mahesh Kandula Compositions and methods for the treatment of inflammatory bowel disease
US9108942B1 (en) 2014-11-05 2015-08-18 Mahesh Kandula Compositions and methods for the treatment of moderate to severe pain
US9187427B2 (en) 2012-08-03 2015-11-17 Cellix Bio Private Limited N-substituted nicotinamide compounds and compositions for the treatment migraine and neurologic diseases
WO2014037833A2 (en) 2012-09-06 2014-03-13 Mahesh Kandula Compositions and methods for the treatment inflammation and lipid disorders
WO2014037834A2 (en) 2012-09-08 2014-03-13 Mahesh Kandula Compositions and methods for the treatment of inflammation and lipid disorders
CN103012463B (zh) * 2013-01-17 2016-02-10 南京理工大学 (s)-3-甲基-2-(叔丁基二甲基硅氧基)-1-溴丁烷的合成方法
US9333187B1 (en) 2013-05-15 2016-05-10 Cellix Bio Private Limited Compositions and methods for the treatment of inflammatory bowel disease
SG11201509782TA (en) 2013-06-04 2015-12-30 Cellix Bio Private Ltd Compositions and methods for the treatment of diabetes and pre-diabetes
US9096537B1 (en) 2014-12-31 2015-08-04 Mahesh Kandula Compositions and methods for the treatment of mucositis
CN103755679A (zh) * 2014-02-14 2014-04-30 宁德新能源科技有限公司 一种亚烷基二磺酸酐的制备方法
MX2016014261A (es) 2014-04-30 2017-05-04 Icahn School Med Mount Sinai Uso de acido 1,3-propandisulfonico o sales farmaceuticamente aceptables del mismo para el tratamiento de sarcoidosis.
CA2976314C (en) 2014-09-26 2021-02-23 Cellix Bio Private Limited Compositions and methods for the treatment of epilepsy and neurological disorders
EP3201168B1 (en) 2014-09-29 2020-03-18 Cellix Bio Private Limited Compounds and compositions for the treatment of multiple sclerosis
AU2014414316B2 (en) 2014-10-27 2020-04-09 Cellix Bio Private Limited Three component salts of fumaric acid monomethyl ester with piperazine or ethylene diamine for the treatment of multiple sclerosis
US9173877B1 (en) 2014-11-05 2015-11-03 Cellix Bio Private Limited Compositions and methods for the treatment of local pain
US9321716B1 (en) 2014-11-05 2016-04-26 Cellix Bio Private Limited Compositions and methods for the treatment of metabolic syndrome
US10208014B2 (en) 2014-11-05 2019-02-19 Cellix Bio Private Limited Compositions and methods for the treatment of neurological disorders
US9284287B1 (en) 2014-11-05 2016-03-15 Cellix Bio Private Limited Compositions and methods for the suppression of carbonic anhydrase activity
US9175008B1 (en) 2014-11-05 2015-11-03 Cellix Bio Private Limited Prodrugs of anti-platelet agents
US9290486B1 (en) 2014-11-05 2016-03-22 Cellix Bio Private Limited Compositions and methods for the treatment of epilepsy
US9150557B1 (en) 2014-11-05 2015-10-06 Cellix Bio Private Limited Compositions and methods for the treatment of hyperglycemia
US9932294B2 (en) 2014-12-01 2018-04-03 Cellix Bio Private Limited Compositions and methods for the treatment of multiple sclerosis
US9206111B1 (en) 2014-12-17 2015-12-08 Cellix Bio Private Limited Compositions and methods for the treatment of neurological diseases
CN110845355A (zh) 2015-01-06 2020-02-28 塞尔利克斯生物私人有限公司 用于治疗炎症和疼痛的组合物和方法
CN109988085B (zh) * 2017-12-29 2021-11-09 张家港市国泰华荣化工新材料有限公司 金属离子含量低的1,3-丙二烷基磺酸的制备方法
WO2020008391A1 (en) 2018-07-06 2020-01-09 Pfizer Inc. Manufacturing process and intermediates for a pyrrolo[2,3- d]pyrimidine compound and use thereof
JP7611824B2 (ja) 2018-11-22 2025-01-10 ナント ユニベルシテ 増殖性疾患の処置で使用するためのジスルホナートスチルベン
JP7324082B2 (ja) * 2019-08-07 2023-08-09 東ソー・ファインケム株式会社 カルボン酸無水物またはスルホン酸無水物の製造方法
CN110818673B (zh) * 2019-11-22 2022-08-16 湖南阿斯达新材料有限公司 一种环状二磺酸亚甲酯的合成方法
CN112574167B (zh) * 2020-12-07 2021-11-09 烟台海川化学制品有限公司 一种甲烷二磺酸亚甲酯的制备方法
EP4349823A4 (en) * 2021-05-31 2024-11-20 Mitsubishi Gas Chemical Company, Inc. NOVEL AMINO COMPOUND AND METHOD FOR THE PRODUCTION THEREOF, AS WELL AS EPOXY RESIN HARDENING AGENT, EPOXY RESIN COMPOSITION AND EPOXY RESIN HARDENED PRODUCT THEREOF
CN115124502B (zh) * 2022-08-03 2024-09-13 张家港市国泰华荣化工新材料有限公司 一种丙烯二磺酸酐的制备方法

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB661537A (en) * 1948-11-24 1951-11-21 Rhone Poulenc Sa Improvements in and relating to the preparation of sulphonyl derivatives of piperazine
BE795839A (fr) * 1972-02-25 1973-08-23 Ciba Geigy Procede de retification de colloides hydrophiles
DD119040A1 (enExample) * 1975-03-11 1976-04-05
DE2547590A1 (de) 1975-10-24 1977-04-28 Agfa Gevaert Ag Neue 1-sulfonyl-4-amino-pyridiniumsalze und verfahren zu ihrer herstellung
US4914091A (en) * 1984-04-02 1990-04-03 American Cyanamid Company Esters of cephalosporin derivitives
TW211080B (enExample) * 1991-12-12 1993-08-11 American Telephone & Telegraph
CA2107644A1 (en) * 1992-10-28 1994-04-29 David R. Magnin .alpha.-phosphonosulfonae squalene synthetase inhibitors and methd
DE4302681A1 (de) * 1993-02-01 1994-08-04 Hoechst Ag Sulfonsäureester, damit hergestellte strahlungsempfindliche Gemische und deren Verwendung
DE69434571T2 (de) 1993-03-29 2006-08-03 Queen's University At Kingston, Kingston Propan-1,3-disulphonsäure und deren pharmazeutisch akzeptable Salze zur Behandlung von Amyloidosis
US5840294A (en) 1993-03-29 1998-11-24 Queen's University At Kingston Method for treating amyloidosis
DE19823722A1 (de) * 1998-05-27 1999-12-02 Merckle Gmbh Chinolinylmethoxyaryl-Verbindungen als duale Inhibitoren der Cyclooxygenase und 5-Lipoxygenase
US6562836B1 (en) 1999-05-24 2003-05-13 Queen's University Of Kingston Methods and compounds for inhibiting amyloid deposits
CN1434706A (zh) * 1999-12-23 2003-08-06 神经化学公司 用于调节脑淀粉状蛋白性血管病的化合物和方法
AU2003302109A1 (en) * 2002-11-21 2004-06-15 Ranbaxy Laboratories Limited Prodrug esters of ceftriaxone
US20050031651A1 (en) * 2002-12-24 2005-02-10 Francine Gervais Therapeutic formulations for the treatment of beta-amyloid related diseases
AU2004249530B2 (en) 2003-06-23 2011-08-18 Kiacta Sarl Improved pharmaceutical drug candidates and methods for preparation thereof
BRPI0411743A (pt) 2003-06-23 2006-08-08 Neurochem Int Ltd método e composições para tratar doenças relacionadas a amilóides
US7253306B2 (en) * 2003-06-23 2007-08-07 Neurochem (International) Limited Pharmaceutical drug candidates and methods for preparation thereof
JP4484681B2 (ja) * 2004-12-03 2010-06-16 富士フイルム株式会社 感光性組成物及び該感光性組成物を用いたパターン形成方法
TW200716088A (en) 2005-04-15 2007-05-01 Neurochem Int Ltd Formulations and methods for treating amyloidosis
AR057771A1 (es) * 2005-08-25 2007-12-19 Pharmacopeia Drug Discovery Agonistas adrenoreceptores alfa2c
GB0523040D0 (en) * 2005-11-11 2005-12-21 Cyclacel Ltd Combination
CN101453999A (zh) 2005-12-22 2009-06-10 神经化学（国际）有限公司 肾病症、糖尿病肾病和血脂异常的治疗
PE20080940A1 (es) * 2006-06-28 2008-07-09 Pfizer Prod Inc Profarmacos de penem
CA2673022A1 (en) * 2006-12-22 2008-07-03 Bellus Health (International) Limited Methods, compounds, and compositions for treating metabolic disorders and diabetes
JP2010513219A (ja) * 2006-12-22 2010-04-30 ベラス ヘルス （インターナショナル） リミテッド 腎臓の疾患、糖尿病性腎症及び脂質代謝異常の治療
US20090069419A1 (en) 2007-09-07 2009-03-12 Bernd Jandeleit Masked carboxylate neopentyl sulfonyl ester cyclization release prodrugs of acamprosate, compositions thereof, and methods of use
WO2009033079A1 (en) * 2007-09-07 2009-03-12 Xenoport, Inc. Externally masked neopentyl sulfonyl ester cyclization release prodrugs of acamprosate, compositions thereof, and methods of use
US20090099253A1 (en) * 2007-10-15 2009-04-16 Xenoport, Inc. Internally Masked Neopentyl Sulfonyl Ester Cyclization Release Prodrugs of Acamprosate, Compositions Thereof, and Methods of Use
JP4961324B2 (ja) 2007-10-26 2012-06-27 富士フイルム株式会社 電子線、ｘ線又はｅｕｖ用ポジ型レジスト組成物及びそれを用いたパターン形成方法
JP2013501733A (ja) * 2009-08-10 2013-01-17 ビーエイチアイ リミテッド パートナーシップ １，３−プロパンジスルホン酸を送達するための方法、化合物、および組成物

Similar Documents

Publication Publication Date Title
JP2013501733A5 (enExample)
KR101472248B1 (ko) 뒤시엔느 근이영양증의 치료
ES2839201T3 (es) Derivados de anillo (hetero)aromático sustituidos en carboxilo y método de preparación y usos de los mismos
RU2476429C2 (ru) Фармацевтическая композиция, содержащая оптически активное соединение, обладающее активностью агониста рецептора тромбопоэтина, и промежуточное соединение для этого
RU2020108523A (ru) Гетероарил-замещенные бета-гидроксиэтиламины для применения для лечения гипергликемии
RU2019110030A (ru) Композиции и способы
JP2013500986A5 (enExample)
JP2013510825A5 (enExample)
JP2016534084A5 (enExample)
RU2018120728A (ru) Лечение остеоартрита
RU2012118667A (ru) Гетероциклические соединения, используемые в качестве ингибиторов pdk1
JP2017528498A5 (enExample)
JP2011527345A5 (enExample)
RU2016143333A (ru) Амидные производные и их фармацевтически приемлемые соли, способ их получения и медицинское применение
JP2012516900A5 (enExample)
JP2010510237A5 (enExample)
JP2010524947A5 (enExample)
RU2018127728A (ru) Слитые трициклические гетероциклические соединения в качестве ингибиторов интегразы вич
JP2010538040A5 (enExample)
JP2010511019A5 (enExample)
RU2013108348A (ru) Конденсированные гетероарилы и их применение
RU2019142472A (ru) Глюкуронидные пролекарства ингибиторов янус-киназы
JP2015536997A5 (enExample)
JP2020516616A5 (enExample)
JP2020520949A5 (enExample)